Recurrent Acromegaly in a Patient With a < em > CHEK2 < /em > Mutation

CONCLUSION: Our data raise the possibility that CHEK2 mutations may be involved in the development of acromegaly. Additional studies are needed to elucidate the potential role of CHEK2 mutations in the pathogenesis of somatotroph adenomas.PMID:35415223 | PMC:PMC8984513 | DOI:10.1016/j.aace.2021.10.006

Source: Clinical Breast Cancer - April 13, 2022 Category: Cancer & Oncology Authors: Milica Perosevic Maria Martinez-Lage Brooke Swearingen Nicholas A Tritos Source Type: research